naltrexone has been researched along with mifepristone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Armario, A; Garvey, JS; Giralt, M; Hidalgo, J | 1 |
| Fishman, J; Lustig, RH; Pfaff, DW | 1 |
| Capasso, A; Cutrufo, C; Di Giannuario, A; Loizzo, A; Palazzesi, S; Pieretti, S; Sorrentino, L | 1 |
| Brown, RD; Fuchs, BA; Harris, LS; Levier, DG; McCay, JA; Munson, AE | 1 |
| Pruett, SB; Wu, WJ | 1 |
| Coe, CL; Erickson, CM | 1 |
| Roberts, AI; Shi, YF; Wei, LX; Zhou, JN | 1 |
| Dhabhar, FS; Engler, H; Padgett, DA; Sheridan, JF; Tseng, RJ | 1 |
| Bagaeva, TR; Iarushkina, NI | 1 |
| Bagaeva, TR; Filaretova, LP; Yarushkina, NI | 1 |
| Clark, JK; Hammond, S; Keralapurath, MM; Wagner, JJ | 1 |
| Bregonzio, C; de Di Nasso, EG; Gamboa, DF; Pennacchio, GE; Soaje, M; Valdez, SR | 1 |
| Ficek, J; Golda, S; Korostynski, M; Piechota, M; Przewlocki, R; Szklarczyk, K | 1 |
| Lyon, J | 1 |
1 review(s) available for naltrexone and mifepristone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for naltrexone and mifepristone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of morphine administration on rat liver metallothionein and zinc metabolism.
Topics: Animals; Immobilization; Injections, Subcutaneous; Liver; Male; Metallothionein; Mifepristone; Morphine; Naloxone; Naltrexone; Rats; Rats, Inbred Strains; Zinc | 1991 |
Induction of LH hypersecretion in cyclic rats during the afternoon of oestrus by oestrogen in conjunction with progesterone antagonism or opioidergic blockade.
Topics: Animals; Estradiol; Estrenes; Estrus; Female; Luteinizing Hormone; Mifepristone; Naltrexone; Narcotic Antagonists; Proestrus; Progesterone; Progestins; Rats; Rats, Inbred Strains; Secretory Rate; Stimulation, Chemical | 1988 |
Opioids and corticosteroids involvement in the regulation of the neocortical spindling episodes in DBA/2J mice.
Topics: Adrenal Cortex; Animals; Cerebral Cortex; Corticosterone; Cycloheximide; Dexamethasone; Disease Models, Animal; Disease Susceptibility; Electroencephalography; Epilepsy; Genetic Predisposition to Disease; Male; Mice; Mice, Inbred DBA; Mifepristone; Morphine; Naltrexone | 1993 |
Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
Topics: Animals; Drug Tolerance; Female; Kupffer Cells; Liver; Macrophages; Mice; Mice, Inbred Strains; Mifepristone; Mononuclear Phagocyte System; Morphine; Naltrexone; Organ Size; Phagocytosis; Spleen | 1993 |
Suppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Animals; Azides; Benzodiazepines; Carbolines; Catecholamines; Corticosterone; Diazepam; Disease Models, Animal; Female; GABA-A Receptor Agonists; Glucocorticoids; Immunity, Cellular; Immunity, Innate; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mifepristone; Nadolol; Naltrexone; Neurosecretory Systems; Oxidopamine; Phentolamine; Picrotoxin; Propranolol; Receptors, GABA-A; Spleen; Sympathetic Nervous System | 1996 |
Stress decreases lymphocyte cytolytic activity in the young monkey even after blockade of steroid and opiate hormone receptors.
Topics: Animals; Cytotoxicity, Immunologic; Female; Hydrocortisone; Killer Cells, Natural; Male; Maternal Deprivation; Mifepristone; Naltrexone; Receptors, Opioid; Receptors, Steroid; Saimiri; Stress, Psychological | 1997 |
Lymphocyte reduction induced by hindlimb unloading: distinct mechanisms in the spleen and thymus.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; fas Receptor; Hindlimb Suspension; Immunoglobulin Fc Fragments; Injections, Intraperitoneal; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mifepristone; Naltrexone; Narcotic Antagonists; Receptors, Steroid; Recombinant Fusion Proteins; Spleen; Thymus Gland | 2003 |
Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids.
Topics: Animals; Glucocorticoids; Hormone Antagonists; Influenza A virus; Killer Cells, Natural; Lymphocyte Count; Male; Mice; Mice, Inbred C57BL; Mifepristone; Naltrexone; Narcotic Antagonists; Neuroimmunomodulation; Orthomyxoviridae Infections; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Restraint, Physical; Spleen; Stress, Physiological | 2005 |
[Mechanisms of corticotropin-releasing factor-induced analgesic effect in conscious rats].
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Corticotropin-Releasing Hormone; Hormone Antagonists; Hormones; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mifepristone; Naltrexone; Narcotic Antagonists; Pain; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 2010 |
Central corticotropin-releasing factor (CRF) may attenuate somatic pain sensitivity through involvement of glucocorticoids.
Topics: Analgesics, Non-Narcotic; Animals; Corticosterone; Corticotropin-Releasing Hormone; Electric Stimulation; Glucocorticoids; Injections, Intraventricular; Male; Mifepristone; Naltrexone; Narcotic Antagonists; Nociceptive Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2011 |
Cocaine- or stress-induced metaplasticity of LTP in the dorsal and ventral hippocampus.
Topics: Animals; Cocaine; Corticosterone; Dopamine Uptake Inhibitors; Drug Administration Schedule; Excitatory Postsynaptic Potentials; Hippocampus; Hormone Antagonists; In Vitro Techniques; Long-Term Potentiation; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Motor Activity; Naltrexone; Rats; Rats, Sprague-Dawley; Spironolactone; Stress, Psychological | 2014 |
Opioid modulation of prolactin secretion induced by stress during late pregnancy. Role of ovarian steroids.
Topics: Analgesics, Opioid; Animals; Estradiol; Female; Mifepristone; Naloxone; Naltrexone; Narcotic Antagonists; Ovary; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Steroids; Tamoxifen | 2014 |
Endogenous opioids regulate glucocorticoid-dependent stress-coping strategies in mice.
Topics: Adaptation, Psychological; Amygdala; Animals; Anxiety; Conditioning, Psychological; Depression; Dexamethasone; Fear; Freezing Reaction, Cataleptic; Glucocorticoids; Male; Mice, Inbred Strains; Mifepristone; Motor Activity; Naltrexone; Neurotransmitter Agents; Opioid Peptides; Receptors, Glucocorticoid; Receptors, Opioid; Species Specificity; Stress, Psychological | 2016 |
More Treatments on Deck for Alcohol Use Disorder.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Amines; Baclofen; Cyclohexanecarboxylic Acids; Cytidine Diphosphate Choline; Disulfiram; Drug Repositioning; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Mifepristone; Naltrexone; National Institute on Alcohol Abuse and Alcoholism (U.S.); Off-Label Use; Patient Acceptance of Health Care; Taurine; Topiramate; United States; Varenicline | 2017 |